# University of Washington School of Medicine

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/university-of-washington-school-of-medicine
Canonical HTML page: https://gethealthbrief.com/entity/university-of-washington-school-of-medicine

## Timeline

- **2026-09-07**: NPR investigation reports injectable GHK-Cu trend — Public radio report documents the shift from topical creams to subcutaneous injection and grey market sourcing, with no published human injectable safety data.
- **1970**: First isolation of GHK — Chemist Loren Pickart isolates Glycyl-L-histidyl-L-lysine after observing that plasma from younger adults helps revive liver cells in the lab.

## Recent coverage (1 stories)

### 50-Year-Old GHK-Cu Peptide Now Injected With 0 Human Safety Trials
2026-09-07 22:36:00 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Injections of GHK-Cu, a copper peptide long sold as a topical cream, are spreading through grey-market sellers without any published human safety or efficacy data. Researchers say the systemic route changes the risk profile and clinicians should ask patients about peptide use.
Full story: https://gethealthbrief.com/story/ghk-cu-injectables-human-safety-gap

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.